Skip to content

Docs (opens in a new tab)Pricing Ideas Benchmark

Sign in Sign up

M

MAZE

Maze Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$29.70

+7.88%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsIdeas

Idea

No published Drillr research on MAZE yet.

Ask Drillr about MAZE Browse research →

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Workspace|Docs (opens in a new tab)|Pricing|Research|Methodology|Privacy|Disclaimer|Contact|© 2026 LIL GREBE INC.